0001011438-12-000170.txt : 20120315 0001011438-12-000170.hdr.sgml : 20120315 20120315133028 ACCESSION NUMBER: 0001011438-12-000170 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111231 FILED AS OF DATE: 20120315 DATE AS OF CHANGE: 20120315 EFFECTIVENESS DATE: 20120315 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Consonance Capital Management LP CENTRAL INDEX KEY: 0001544773 IRS NUMBER: 260294313 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14924 FILM NUMBER: 12693266 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212.660-8062 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 43RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 13F-HR 1 form_13f-consonance.txt ----------------------------------- OMB APPROVAL ----------------------------------- OMB Number: 3235-0006 Expires: August 31, 2012 Estimated average burden hours per response..........22.6 ----------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2011 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Consonance Capital Address: 888 Seventh Avenue, 43rd Floor New York, New York 10019 Form 13F File Number: The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Kevin H. Livingston Title: Managing Director Phone: 212-660-8060 Signature, Place, and Date of Signing: /s/ Kevin H. Livingston New York, New York March 15, 2012 ----------------------- ------------------- ------------------ [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT.(Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F Summary Page Report Summary: Number of Other Included Managers: 0 ------- Form 13F Information Table Entry Total: 15 ------- Form 13F Information Table Value Total: $92,584 ------- (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name --- -------------------- ----
Consonance Capital Form 13F Information Table Quarter ended December 31, 2011 COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 VALUE SHRS or SH/ PUT/ INVE OTH VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISC MAN SOLE SHARED NONE ---------------------------- -------------- --------- --------- --------- --- ---- ---- --- --------- ------ ---- ABAXIS INC COM 002567105 $ 3,154 114,000 SH SOLE 114,000 BIOSCRIP INC COM 09069N108 $ 6,427 1,177,061 SH SOLE 1,177,061 COMPUTER PROGRAMS & SYS INC COM 205306103 $ 5,841 114,274 SH SOLE 114,274 DERMA SCIENCES INC COM PAR $.01 249827502 $ 305 40,216 SH SOLE 40,216 EXPRESS SCRIPTS INC COM 302182100 $ 9,590 214,600 SH SOLE 214,600 JAZZ PHARMACEUTICALS INC COM 472147107 $ 15,977 413,600 SH SOLE 413,600 MEDCATH CORP COM 58404W109 $ 816 111,957 SH SOLE 111,957 MEDICINES CO COM 584688105 $ 4,235 227,200 SH SOLE 227,200 NATUS MEDICAL INC DEL COM 639050103 $ 3,983 422,422 SH SOLE 422,422 OPTIMER PHARMACEUTICALS INC COM 68401H104 $ 4,479 365,946 SH SOLE 365,946 QUESTCOR PHARMACEUTICALS INC COM 74835Y101 $ 15,798 379,952 SH SOLE 379,952 SAGENT PHARMACEUTICALS INC COM 786692103 $ 6,057 288,449 SH SOLE 288,449 SANTARUS INC COM 802817304 $ 6,939 2,096,370 SH SOLE 2,096,370 SHANGPHARMA CORP SPONSORED ADR 81943P104 $ 3,749 515,701 SH SOLE 515,701 WUXI PHARMATECH CAYMAN INC SPONS ADR SHS 929352102 $ 5,234 474,100 SH SOLE 474,100 Total Fair Market Value (in thousands): $ 92,584